American Journal of Hospice and Palliative Medicine® · 2008 · 39 citations · 12 references
MedicineOncologyPharmacotherapyPalliative CarePalliative MedicinePalliative OncologyThromboembolic DiseaseThromboembolism PreventionThrombosisThrombosis ManagementThrombosis PreventionVenous ThromboembolismProphylactic AnticoagulationThromboprophylaxis In Cancer PatientsThromboprophylaxis In Medical InpatientsVirtual Patient Simulation
Study-based guidelines on thromboprophylaxis are not available for palliative care patients. The authors asked a panel of academic medical experts in palliative care, oncology, blood coagulation, and intensive care to select a prophylactic regimen out of 5 predefined options for a virtual patient with advanced bronchial cancer in different clinical settings. Primary prophylaxis for venous thromboembolism was withdrawn by all physicians when the patient had a Karnovsky's index of 10 and was described as dying. It was given by 25% of physicians when the patient had a Karnovsky's index of 20 and by 85% when Karnovsky's index 40 was still 40. Similar results were obtained in the situation of secondary prophylaxis of venous thromboembolism and when the patient was described as having a history of chronic atrial fibrillation. This data clearly show that thromboprophylaxis is delivered according to a compound estimate of risks and benefits of such prophylaxis in a specific palliative care situation.
12
Malignancies, Prothrombotic Mutations, and the Risk of Venous Thrombosis
Jeanet W. Blom · JAMA · 2005 · 2K citations
Medicine, Genetics, Hematology +14
Barbara A. Hutten, Martin H. Prins, Michael Gent et al. · Journal of Clinical Oncology · 2000 · 753 citations
Ajay K. Kakkar, Mark N. Levine, Zbigniew Kadziola et al. · Journal of Clinical Oncology · 2004 · 654 citations · Full text
Medicine, Oncology, Pharmacology +13